1420 Fifth Avenue Suite 3700, Seattle, WA USA 98101
Avi Bayer is a Patent Scientist/Engineer who focuses on patent prosecution related to life sciences, biotechnology, and pharmaceutical matters. He has expertise across various fields including molecular biology, microbiology, gene editing, virology, immunotherapies, cellular therapies, pharmaceuticals, immunology, genomics, sequencing, developmental biology, and evolutionary biology.
Prior to joining the firm, Avi worked for nearly 14 years as a post-graduate researcher, including eight years as a postdoctoral research fellow, at a major cancer research institution. Avi’s postdoctoral work focused on the evolution of the human immune system to block viral infection. In particular, his work revealed human adaptation to inhibit herpesvirus infections, unique among primates. Through various research projects, Avi gained expertise in broad molecular biology techniques including gene editing with CRISPR/CAS systems and lentiviral vectors. His doctoral work focused on host-pathogen interactions at the maternal-fetal interface and understanding the molecular mechanisms by which the placenta and maternal immune system protect the developing fetus from viral infections. This included constitutive expression of type III interferons and secretion of microRNAs packaged into exosomes.
Insights View All
Publication
Pitzer College B.A., Religious Studies (2007)
State University of New York at Purchase B.S., Cell and Molecular Biology (2011)
University of Pittsburgh School of Medicine Ph.D., Molecular Virology and Microbiology (2016)
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
